Retatrutide vs. Tirzepatide: Where the 2026 Research Stands
A literature roundup comparing the peer-reviewed trial data behind retatrutide and tirzepatide — and why no head-to-head study between them has been published.
Research News
Research News articles
New Peptide Research Published This Quarter (Q2–Q3 2026)
A recurring roundup of newly published, PubMed-indexed peptide research — this installment covers BPC-157's first human safety data and a new NAD+ precursor trial.
FDA Compounding Policy Update: What It Means for RUO Peptide Supply
A summary of recent regulatory developments affecting compounding and research-use peptide supply chains.
Selank vs. Semax: Comparing Two Russian Neuropeptide Research Lines
A side-by-side look at Selank and Semax — two ACTH/tuftsin-derived heptapeptides from the same research tradition, their distinct mechanisms, and the one study that examined both together.